Overall, the upregulation of TXNIP was observed and implicated in pathological pathways in vivo and in vitro in the NS model, UUO-induced renal fibrosis model, aging-related renal fibrosis model, DN model, and human proteinuric kidney diseases. The gene discussed is TXNIP; the disease is liver dysplastic nodule.